The mechanisms involved in autoimmunity during the pathogenesis of T1D include factors of humoral immunity, such as the presence of circulating autoantibodies (anti-insulin, among other islet autoantibodies), that can be used as biomarkers of the disease (2–4). This evidence concerns the gene INS and Autoimmunity.